Essa Pharma inc (EPIX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access EPIX Annual Balance Sheets →
The data below summarizes Essa Pharma inc's balance sheet position from Jun 30 2024 to Jun 30 2025, enabling a period-by-period comparison of financial strength.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2025)
(Mar 31 2025) (Dec 31 2024) (Sep 30 2024) (Jun 30 2024)
Assets
Cash & cash equivalent85.95
Short-term Investments, Total0.02
Cash & Short-term Investments85.00
Accounts receivable0.53
Other Current Assets0.00
Prepaid Expense, Current AS0.36
Total Current Assets110.50
Deposits Assets, Noncurrent AS0.00
Tax Assets, Noncurrent0.00
Deferred, Prepaid and Other Assets, Noncurrent0.02
Other Assets, Noncurrent23.63
Operating Lease Right Of Use Asset-
Total Assets110.50
Liabilities
Accounts Payable and Accrued Liabilities, Current LI1.60
Accrued Liabilities, Current0.45
Other Liabilities, Current0.00
Total Current Liabilities1.60
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Operating Lease Liability Current-
Operating Lease Liability Noncurrent-
Total Liabilities1.60
Stockholders' Equity
Common Stock Value279.86
Additional Paid In Capital Common Stock58.05
Retained Earnings / Accumulated Deficit-226.91
Accumulated Other Comprehensive Income-2.10
Other Equity-2.10
Common Stockholder's Equity108.90
Total Stockholder's Equity108.90
Liabilities & Stockholder's Equity110.50
4 historic quarters locked

Sign in to unlock the full Essa Pharma inc balance sheet history.

About Essa Pharma Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001558370-25-011295

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.